Skip to main content

Your search for “Cancer Drugs” returned 582 results

Southern California’s First Real-Time MRI-Guided Gene Therapy for Brain Cancer

August 6, 2013

Neurosurgeons at the University of California, San Diego School of Medicine and UC San Diego Moores Cancer Center are among the first in the world to utilize real-time magnetic resonance imaging (MRI) guidance for delivery of gene therapy as a potential treatment for brain tumors.

Stand Up To Cancer Grant Funds UC San Diego Health Research in Pancreatic Cancer

November 20, 2018

A team of University of California San Diego School of Medicine researchers have been awarded a $1 million Stand Up To Cancer (SU2C) grant to test drugs that block signals that play a critical role in driving growth and progression of pancreatic cancer.

State’s Stem Cell Agency Awards $18.2 Million Grant for B Cell Cancer Clinical Trial

August 24, 2017

The Independent Citizens Oversight Committee of the California Institute for Regenerative Medicine (CIRM) today unanimously approved an $18.29 million grant to University of California San Diego School of Medicine researchers to fund a phase Ib/IIa clinical trial of a novel combination drug therapy for B-cell cancers.

Combined Chemotherapy and Immunotherapy Shows Promise for Advanced Prostate Cancers

April 29, 2015

…near complete remission in mouse models of advanced prostate cancer. The study is published April 29 in Nature.

One-Two Punch: Novel Drug Pairing Could Beat Pancreatic Cancer

June 28, 2023

UC San Diego researchers find a combination of drugs outperformed other treatments in human and mouse models of pancreatic cancer; now urge clinical trial

UC San Diego Biophysicists Examine Development of Antibiotic Resistance

December 5, 2013

…antibiotics and developing new drugs against bacteria already resistant to conventional drug treatments. But understanding how bacteria grow and evolve drug resistance could also help stop its spread by allowing scientists to target the process of evolution itself. “Understanding how bacteria harboring antibiotic resistance grow in the presence of antibiotics…

Enzyme Offers New Therapeutic Target for Cancer Drugs

June 21, 2012

…new pathway might be a fruitful target for new cancer drugs.

UC San Diego Researcher Gets $4 Million NCI Award to Study Cancer Drug Resistance, Spread

December 7, 2018

David Cheresh, Distinguished Professor at University of California San Diego School of Medicine, received $4.2 million National Cancer Institute Outstanding Investigator Award to continue his research into cancer’s ability to overcome stress, gain drug resistance and metastasize.

UC San Diego/SDSC Study Uncovers Mechanism to Block a Cancer Pathway

October 20, 2015

…most common types of cancer. This important drug has now been shown to play an unexpected role in blocking one of the pathways most commonly involved in driving the growth of cancers, according to a recent study by researchers at the San Diego Supercomputer Center (SDSC) as well as the…

Clinical Trial Evaluates Synthetic Cannabinoid as Brain Cancer Treatment

September 25, 2012

Researchers at University of California, San Diego Moores Cancer Center are evaluating the safety and tolerability of a synthetic cannabinoid called dexanabinol (ETS2101). Delivered as a weekly intravenous infusion, the drug is being tested in patients with all forms of brain cancer, both primary and metastatic.

Category navigation with Social links